MHS
MRNA icon

M Holdings Securities’s Moderna MRNA Stock Holding History

M Holdings Securities’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,303
Closed -$354K – 364
2023
Q1 		$354K Sell
2,303
-20
-0.9% -$3.3K 0.04% 321
2022
Q4 		$417K Sell
2,323
-200
-8% -$32.7K 0.04% 286
2022
Q3 		$298K Sell
2,523
-8
-0.3% -$1.21K 0.03% 325
2022
Q2 		$362K Buy
2,531
+33
+1% +$4.72K 0.04% 301
2022
Q1 		$430K Buy
+2,498
New +$421K 0.03% 323

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

M Holdings Securities's MRNA Position: Q2 2023 in Review

M Holdings Securities sold out of Moderna (MRNA) in Q2 2023, closing a stake of 2,303 shares — an estimated $354K sold.

M Holdings Securities first reported a position in MRNA in Q1 2022 and held it in 5 quarters. The position peaked at $430K in Q1 2022. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • M Holdings Securities reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • M Holdings Securities sold 2,303 Moderna shares in Q2 2023, an estimated $354K.
  • M Holdings Securities first reported a position in Moderna in Q1 2022 and held it in 5 quarters.
  • M Holdings Securities's Moderna position peaked at $430K in Q1 2022.
  • 965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on M Holdings Securities's 13F filing for Q2 2023, filed 26 Sep 2023.